Main Activity in Nanotechnology
Critical Pharmaceuticals is a venture capital funded, product development company that creates high value added therapeutics by applying its breakthrough, and proprietary, technology to transform the drug delivery of challenging molecules. The company’s focus is on approved recombinant protein therapeutics (biologics) where current technologies cannot create the highly active drug delivery systems that are needed. For biologics such as human growth hormone, erythropoietin (EPO) and beta-interferon the current technologies often damage the biologic and/or leave potentially toxic solvent residues in the final product. Critical Pharmaceuticals solves these problems with a simple, one-step, patented formulation process.